Purpose of Review: Diabetes mellitus can be categorized into two major variants, type 1 and type 2. A number of traits such as clinical phenotype, age at disease onset, genetic background, and underlying pathogenesis distinguish the two forms. Recent Findings: Recent evidence indicates that type 1 diabetes can be accompanied by insulin resistance and type 2 diabetes exhibits self-reactivity. These two previously unknown conditions can influence the progression and outcome of the disease. Unlike most conventional considerations, diabetes appears to consist of a spectrum of intermediate phenotypes that includes monogenic and polygenic loci linked to inflammatory processes including autoimmunity, beta cell impairment, and insulin resistance. Summary: Here we discuss why a shift of the classical bi-modal view of diabetes (autoimmune vs. non-autoimmune) is necessary in favor of a model of an immunological continuum of endotypes lying between the two extreme “insulin-resistant” and “autoimmune beta cell targeting,” shaped by environmental and genetic factors which contribute to determine specific immune-conditioned outcomes.
Petrelli, A., Giovenzana, A., Insalaco, V., Phillips, B., Pietropaolo, M., Giannoukakis, N. (2021). Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes. CURRENT DIABETES REPORT, 21(12) [10.1007/s11892-021-01430-3].
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes
Giovenzana A.;
2021
Abstract
Purpose of Review: Diabetes mellitus can be categorized into two major variants, type 1 and type 2. A number of traits such as clinical phenotype, age at disease onset, genetic background, and underlying pathogenesis distinguish the two forms. Recent Findings: Recent evidence indicates that type 1 diabetes can be accompanied by insulin resistance and type 2 diabetes exhibits self-reactivity. These two previously unknown conditions can influence the progression and outcome of the disease. Unlike most conventional considerations, diabetes appears to consist of a spectrum of intermediate phenotypes that includes monogenic and polygenic loci linked to inflammatory processes including autoimmunity, beta cell impairment, and insulin resistance. Summary: Here we discuss why a shift of the classical bi-modal view of diabetes (autoimmune vs. non-autoimmune) is necessary in favor of a model of an immunological continuum of endotypes lying between the two extreme “insulin-resistant” and “autoimmune beta cell targeting,” shaped by environmental and genetic factors which contribute to determine specific immune-conditioned outcomes.File | Dimensione | Formato | |
---|---|---|---|
CC BY 4.0 Petrelli-2021-Current Diabetes Reports-VoR.pdf
accesso aperto
Descrizione: This article is licensed under a Creative Commons Attribution 4.0 International License To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
991.96 kB
Formato
Adobe PDF
|
991.96 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.